SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001169245-23-000045
Filing Date
2023-08-25
Accepted
2023-08-25 12:31:30
Documents
5
Period of Report
2023-06-30
Effectiveness Date
2023-08-25

Document Format Files

Seq Description Document Type Size
1 NT 10-Q phasebio-nt10xqq22023.htm NT 10-Q 12026
2 phasebio-nt10xqq22023001.jpg GRAPHIC 106682
3 phasebio-nt10xqq22023002.jpg GRAPHIC 174023
4 phasebio-nt10xqq22023003.jpg GRAPHIC 295933
5 phasebio-nt10xqq22023004.jpg GRAPHIC 101483
  Complete submission text file 0001169245-23-000045.txt   947625
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 231205330
SIC: 2834 Pharmaceutical Preparations